CAGRI
CAGRI is a synthetic 37-amino acid long-acting analog of human amylin, structurally modified with a fatty acid side chain to extend receptor binding duration and stability in laboratory settings. Supplied as a lyophilized powder in a 3mL vial, it is intended exclusively for in vitro laboratory research by qualified scientific personnel.
This peptide has been utilized in preclinical studies examining amylin receptor binding kinetics, glucose-dependent glucagon suppression mechanisms, gastric motility signaling in cell models, appetite hormone pathway interactions, and hypothalamic signaling dynamics — independent of the broader metabolic effects associated with endogenous amylin activity.
Product Details
- Form: Lyophilized powder (for laboratory research)
- Amounts: 5 mg or 10 mg per vial
- Purity: ≥ 98% (HPLC tested)
- Sequence: Ac-[25-37] amylin analogue (linear peptide, 36 amino acids with modifications for stability)
- Molecular Formula: C₁₈₀H₂₈₈N₅₀O₅₃S
- Molecular Weight: ~3900 Da
- Intended Use: Laboratory research only
DISCLAIMER: This product is strictly to be used for scientific research use only. It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes.
We recommend you review our Terms of Service if you have questions about product use.
